echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > National Cancer Prevention and Treatment Week | Big coffee experts talk about the current status and latest progress of gastrointestinal cancer prevention and treatment

    National Cancer Prevention and Treatment Week | Big coffee experts talk about the current status and latest progress of gastrointestinal cancer prevention and treatment

    • Last Update: 2021-04-22
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Currently,Gastric cancer , colorectal colorectal cancer , esophageal cancer, etc.


    Gastric cancer colorectal cancer medsci.


    Be alert to the risk of gastrointestinal tumors, and strive to achieve "three early"

    The WHO IARC report shows that among the new cases of digestive system tumors in China, gastric cancer and colorectal cancer account for the highest proportion.


    infection

    In addition, the current domestic incidence of colorectal cancer, which is increasing year by year, is often caused by polyps.


    Professor Li Jin, Director of the Department of Oncology, Shanghai Dongfang Hospital

    Professor Li Jin, Director of the Department of Oncology, Shanghai Dongfang Hospital, Professor Li Jin, Director of the Department of Oncology , Shanghai Dongfang Hospital

    For patients with early gastric cancer and colorectal cancer, surgical radical resection can be adopted, which has a significant effect.


    Screening diagnosis

    Light up the road to anti-cancer, innovative treatments are expected to benefit more patients

    Light up the road to anti-cancer, innovative treatments are expected to benefit more patients

    If you unfortunately suffer from gastrointestinal tumors, you don’t have to lose your confidence.


    immunity

    Studies have shown that the occurrence of malignant tumors is closely related to oncogenes.


    Pancreatic cancer

    Currently, under the leadership of Professor Li Jin, the Oncology Department of Shanghai Oriental Hospital is cooperating with Boehringer Ingelheim to conduct a global clinical study on KRAS mutant colorectal cancer.


    Tumor is the key area of ​​Boehringer Ingelheim.


    Dr.


    Boehringer Ingelheim is responsible for clinical development and medical Greater China, Dr.


    The theme of this year’s National Cancer Prevention and Control Awareness Week is "Healthy Chinese Health Home-Caring for Life, Scientifically Preventing Cancer".


    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.